LYNN HEALTH SCIENCE INSTITUTE IS LOOKING FOR PARTICIPANTS
PAID CLINICAL TRIAL
- Lasting 15 months
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA
- High risk immunocompromised
- Age 12 and older
Learn more about our locationDenver, Colorado
We are doing this study to learn more about the safety of a study drug called, AZD3152, and to better understand if it may protect people from COVID-19. The study drug, AZD3152, is one component of a combination of 2 proteins named AZD5156
(AZD1061 [cilgavimab] and AZD3152). These proteins are called ‘monoclonal antibodies’. Antibodies are made by the body to help fight infections.
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation ProgramParticipation Information